Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_assertion type Assertion NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_head.
- NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_assertion description "[Further fusions and activating mutations in BRAF were identified in 28% of grade II astrocytomas, highlighting the importance of the ERK/MAP kinase pathway in the development of paediatric low-grade gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_provenance.
- NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_assertion evidence source_evidence_literature NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_provenance.
- NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_assertion SIO_000772 19373855 NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_provenance.
- NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_assertion wasDerivedFrom befree-20150227 NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_provenance.
- NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_assertion wasGeneratedBy ECO_0000203 NP890119.RAVRlBiqleKXTkM-yF_VfHuCStNLW5szHZaYKzG2PQC04130_provenance.